| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |